These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22925211)

  • 1. Developmental neurotoxicity testing: scientific approaches towards the next generation to protect the developing nervous system of children. An overview of the Developmental Neurotoxicity Symposium in 2011.
    Aoyama H
    Congenit Anom (Kyoto); 2012 Sep; 52(3):119-21. PubMed ID: 22925211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity.
    Ema M; Fukui Y; Aoyama H; Fujiwara M; Fuji J; Inouye M; Iwase T; Kihara T; Oi A; Otani H; Shinomiya M; Sugioka K; Yamano T; Yamashita KH; Tanimura T;
    Congenit Anom (Kyoto); 2007 Jun; 47(2):74-6. PubMed ID: 17504392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental neurotoxicity testing: a path forward.
    Crofton KM; Mundy WR; Shafer TJ
    Congenit Anom (Kyoto); 2012 Sep; 52(3):140-6. PubMed ID: 22925214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings.
    Li AA; Sheets LP; Raffaele K; Moser V; Hofstra A; Hoberman A; Makris SL; Garman R; Bolon B; Kaufmann W; Auer R; Lau E; Vidmar T; Bowers WJ
    Neurotoxicol Teratol; 2017 Sep; 63():24-45. PubMed ID: 28757310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation.
    Tsuji R; Crofton KM
    Congenit Anom (Kyoto); 2012 Sep; 52(3):122-8. PubMed ID: 22925212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
    Crofton KM; Mundy WR; Lein PJ; Bal-Price A; Coecke S; Seiler AE; Knaut H; Buzanska L; Goldberg A
    ALTEX; 2011; 28(1):9-15. PubMed ID: 21311847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental neurotoxicity test guidelines: problems and perspectives.
    Tohyama C
    J Toxicol Sci; 2016; 41(Spec):SP69-SP79. PubMed ID: 28250285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting report: alternatives for developmental neurotoxicity testing.
    Lein P; Locke P; Goldberg A
    Environ Health Perspect; 2007 May; 115(5):764-8. PubMed ID: 17520065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes.
    Crofton K; Fritsche E; Ylikomi T; Bal-Price A
    ALTEX; 2014; 31(2):223-4. PubMed ID: 24794006
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of developmental neurotoxicity: an industry perspective.
    Kaufmann W
    Toxicol Lett; 2003 Apr; 140-141():161-9. PubMed ID: 12676463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes.
    Bal-Price A; Crofton KM; Leist M; Allen S; Arand M; Buetler T; Delrue N; FitzGerald RE; Hartung T; Heinonen T; Hogberg H; Bennekou SH; Lichtensteiger W; Oggier D; Paparella M; Axelstad M; Piersma A; Rached E; Schilter B; Schmuck G; Stoppini L; Tongiorgi E; Tiramani M; Monnet-Tschudi F; Wilks MF; Ylikomi T; Fritsche E
    Arch Toxicol; 2015 Feb; 89(2):269-87. PubMed ID: 25618548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation.
    Bal-Price AK; Coecke S; Costa L; Crofton KM; Fritsche E; Goldberg A; Grandjean P; Lein PJ; Li A; Lucchini R; Mundy WR; Padilla S; Persico AM; Seiler AE; Kreysa J
    ALTEX; 2012; 29(2):202-15. PubMed ID: 22892558
    [No Abstract]   [Full Text] [Related]  

  • 13. Overview of neurotoxicology.
    Tilson HA
    Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.1. PubMed ID: 20957638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).
    Terron A; Bennekou SH
    Toxicol Appl Pharmacol; 2018 Sep; 354():19-23. PubMed ID: 29454059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Regulatory and Scientific Effort for Improved Developmental Neurotoxicity Testing.
    Sachana M; Bal-Price A; Crofton KM; Bennekou SH; Shafer TJ; Behl M; Terron A
    Toxicol Sci; 2019 Jan; 167(1):45-57. PubMed ID: 30476307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the developmental neurotoxicity of compounds by measuring locomotor activity in zebrafish embryos and larvae.
    Selderslaghs IW; Hooyberghs J; Blust R; Witters HE
    Neurotoxicol Teratol; 2013; 37():44-56. PubMed ID: 23357511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity.
    Hass U
    Reprod Toxicol; 2006 Aug; 22(2):148-56. PubMed ID: 16777374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
    Llorens J; Li AA; Ceccatelli S; Suñol C
    Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.
    Aschner M; Ceccatelli S; Daneshian M; Fritsche E; Hasiwa N; Hartung T; Hogberg HT; Leist M; Li A; Mundi WR; Padilla S; Piersma AH; Bal-Price A; Seiler A; Westerink RH; Zimmer B; Lein PJ
    ALTEX; 2017; 34(1):49-74. PubMed ID: 27452664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
    Bal-Price A; Hogberg HT; Crofton KM; Daneshian M; FitzGerald RE; Fritsche E; Heinonen T; Hougaard Bennekou S; Klima S; Piersma AH; Sachana M; Shafer TJ; Terron A; Monnet-Tschudi F; Viviani B; Waldmann T; Westerink RHS; Wilks MF; Witters H; Zurich MG; Leist M
    ALTEX; 2018; 35(3):306-352. PubMed ID: 29485663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.